ALS (Lou Gehrig's disease) · Los Angeles

ALS (Lou Gehrig's disease) clinical trials in Los Angeles

2 recruiting amyotrophic lateral sclerosis studies within range of Los Angeles. Click any trial for full eligibility criteria and contact info.

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

NCT04363684 · Frontotemporal Lobar Degeneration (FTLD), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)

Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

Phase—

TypeObservational

Age18 Years

WhereBirmingham, Alabama, United States + 26 more

SponsorMayo Clinic

▾Tap for detailsClick for full details — eligibility, all locations, contacts

27 sitesApply

Apply Open full pageClinicalTrials.gov ↗

HEALEY ALS Platform Trial - Master Protocol

NCT04297683 · Amyotrophic Lateral Sclerosis

Recruiting

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.

PhasePhase 2 / Phase 3

TypeInterventional

Age18 Years

WherePhoenix, Arizona, United States + 74 more

SponsorMerit E. Cudkowicz, MD

▾Tap for detailsClick for full details — eligibility, all locations, contacts

75 sitesApply

Apply Open full pageClinicalTrials.gov ↗

← All amyotrophic lateral sclerosis trials (nationwide)